Literature DB >> 22383444

Detection of carbapenemase-producing Enterobacteriaceae with a commercial DNA microarray.

James Cohen Stuart1, Guido Voets1, Jelle Scharringa1, Ad C Fluit1, Maurine A Leverstein-Van Hall2,1.   

Abstract

The Check-MDR CT102 DNA microarray enables detection of the most prevalent carbapenemases (NDM, VIM, KPC, OXA-48 and IMP) and extended-spectrum β-lactamase (ESBL) gene families (SHV, TEM and CTX-M). The test performance of this microarray was evaluated with 95 Enterobacteriaceae isolates suspected of being carbapenemase producers, i.e. with meropenem MICs ≥0.5 mg l(-1). The collection of isolates contained 70 carbapenemase-producing isolates, including 37 bla(KPC)-, 20 bla(VIM)-, five bla(OXA-48)-, four bla(KPC)/bla(VIM)- and four bla(NDM)-positive isolates; and 25 carbapenemase-gene-negative isolates. ESBLs were produced by 51 of the isolates. PCR and sequencing of β-lactamase genes was used as reference test. For detection of carbapenemases, the sensitivity of the microarray was 97% (68/70), with 100% specificity. The two negative isolates tested positive when the microarray test was repeated; these isolates were an OXA-48- and a KPC-producing isolate. For ESBL detection, the sensitivity was 100% (51/51) and the specificity was 98% (43/44), although 20% of the SHV-12 ESBLs were categorized as SHV-2-like ESBLs. In conclusion, the CDT102 microarray is a rapid and accurate tool for the detection of carbapenemase and ESBL genes, although the array seems less suitable for epidemiology of ESBL genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22383444     DOI: 10.1099/jmm.0.041673-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

1.  Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR.

Authors:  Martin Kaase; Florian Szabados; Lars Wassill; Sören G Gatermann
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  Rapid and simultaneous detection of genes encoding Klebsiella pneumoniae carbapenemase (blaKPC) and New Delhi metallo-β-lactamase (blaNDM) in Gram-negative bacilli.

Authors:  Scott A Cunningham; Tabassum Noorie; Daniele Meunier; Neil Woodford; Robin Patel
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

3.  Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Authors:  Kathleen Chiotos; Jennifer H Han; Pranita D Tamma
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

Review 4.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  Direct detection and genotyping of Klebsiella pneumoniae carbapenemases from urine by use of a new DNA microarray test.

Authors:  Harald Peter; Kathrine Berggrav; Peter Thomas; Yvonne Pfeifer; Wolfgang Witte; Kate Templeton; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

6.  Evaluation of a Commercial Multiplex PCR for Rapid Detection of Multi Drug Resistant Gram Negative Infections.

Authors:  Ruchir Chavada; Michael Maley
Journal:  Open Microbiol J       Date:  2015-08-31

Review 7.  Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management.

Authors:  Hagen Frickmann; Wycliffe Omurwa Masanta; Andreas E Zautner
Journal:  Biomed Res Int       Date:  2014-09-17       Impact factor: 3.411

8.  Rapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assay.

Authors:  Sascha D Braun; Stefan Monecke; Alexander Thürmer; Antje Ruppelt; Oliwia Makarewicz; Mathias Pletz; Annett Reiβig; Peter Slickers; Ralf Ehricht
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

Review 9.  Early diagnosis of resistant pathogens: how can it improve antimicrobial treatment?

Authors:  Sanjay Bhattacharya
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

Review 10.  A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous.

Authors:  Apostolos Liakopoulos; Dik Mevius; Daniela Ceccarelli
Journal:  Front Microbiol       Date:  2016-09-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.